Post-PCI Bleeding Rates Vary Widely Across Hospitals

This article originally appeared here.
Share this content:
Post-PCI Bleeding Rates Vary Widely Across Hospitals
Post-PCI Bleeding Rates Vary Widely Across Hospitals

(HealthDay News) -- Patient case-mix and procedural factors may contribute to wide variation in the hospital rates of bleeding after percutaneous coronary intervention (PCI), according to research published online Nov. 25 in Circulation: Cardiovascular Quality and Outcomes.

Connie N. Hess, M.D., of the Duke Clinical Research Institute in Durham, N.C., and colleagues examined rates and contributing factors for hospital-level variation in post-PCI bleeding. Using data from 1,984,998 procedures performed at 1,292 National Cardiovascular Data Registry hospitals, bleeding rates were compared before and after adjustment using the newly revised CathPCI Registry bleeding risk model.

The researchers found that the unadjusted post-PCI bleeding rate ranged from 2.6 to 10.4 percent, with a median rate of 5.2 percent. Variation in bleeding rates across centers persisted following adjustment for case-mix (2.8 to 9.5 percent; fifth, 95th percentiles). Individual rankings for bleeding rates shifted after risk adjustment. Hospital use of bleeding avoidance strategies, such as bivalirudin, radial access, or vascular closure devices, was associated with reduced bleeding rates.

"Our findings support the CathPCI Registry's use of PCI-related bleeding as a site performance measure and potential incorporation of this metric into other PCI registries," the authors write.

Several authors disclosed financial ties to pharmaceutical and biomedical companies.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Vit D Independently, Inversely Tied to Cholesterol in Children

Vit D Independently, Inversely Tied to Cholesterol in ...

Gene variants do not modify the associations of 25(OH)D with lipids

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for nine of 10 patients with virology failure, rebound

Weight Gain After Quitting Smoking May Up T2DM Risk

Weight Gain After Quitting Smoking May Up T2DM ...

But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality

is free, fast, and customized just for you!




Already a member?

Sign In Now »